Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
2.020
-0.120 (-5.61%)
At close: Mar 6, 2026, 4:00 PM EST
2.030
+0.010 (0.50%)
After-hours: Mar 6, 2026, 5:49 PM EST
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $7.38 million as of March 6, 2026. Its market cap has decreased by -77.58% in one year.
Market Cap
7.38M
Enterprise Value
3.29M
1-Year Change
-77.58%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $7.38M, a decrease of -95.55%. That is a compound annual growth rate of -25.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.38M | -9.42% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaCyte Biotech | 8.08M |
| Alaunos Therapeutics | 8.06M |
| KALA BIO | 7.86M |
| Ernexa Therapeutics | 7.72M |
| Alzamend Neuro | 7.53M |
| Addex Therapeutics | 7.49M |
| GridAI Technologies | 7.40M |
| Kiora Pharmaceuticals | 7.26M |